David McCall, Senior Editor, Cell & Gene Therapy Insights, speaks to TJ Cradick, Chief Scientific Officer, Excision BioTherapeutics, reflecting on his 20-year career in gene editing and discussing the cutting edge in multiplexing with CRISPR
Please note all fields marked with an * are mandatory
To personalise your emails with journal updates relevant to you, please use the tick boxes below to select journals of interest:
To further personalise your emails with interest updates relevant to you, please use the tick boxes below to select areas of interest:
If you have any problem accessing our content, please email info@insights.bio
Welcome back to Bioinsights, please log in to access this content
